Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03338088
Other study ID # INSTITUTO DE OLHOS-MAYRA 2018
Secondary ID
Status Active, not recruiting
Phase N/A
First received November 7, 2017
Last updated November 19, 2017
Start date September 1, 2017
Est. completion date December 30, 2017

Study information

Verified date November 2017
Source Instituto de Olhos de Goiania
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia using Morisky Adhesion scale as a validated questionary.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 150
Est. completion date December 30, 2017
Est. primary completion date November 6, 2017
Accepts healthy volunteers No
Gender All
Age group 1 Year to 100 Years
Eligibility Inclusion Criteria: have glaucoma diagnosed -

Exclusion Criteria: not having glaucoma diagnosed

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Brazil Instituto de Olhos de Goiania Goiania GO
Brazil Instituto de Olhos de Goiania Goiânia Goias

Sponsors (1)

Lead Sponsor Collaborator
Instituto de Olhos de Goiania

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia evaluation of the scale 2 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04007276 - The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Phase 4
Recruiting NCT03220490 - Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops N/A
Completed NCT05319470 - Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives
Completed NCT03323164 - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Phase 4
Recruiting NCT04178863 - CATS Tonometer IOP Reduction Latanoprost Verses Timolol Phase 4
Enrolling by invitation NCT04381611 - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Not yet recruiting NCT03595865 - Efficacy of Tafluprost as an Adjunct to Medical Therapy for Residual Glaucoma After Trabeculectomy N/A
Recruiting NCT06369077 - How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? Phase 4